Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04209530 · ClinicalTrials.gov registry record · Phase 2
Impact of CCH Treatment of Buttock and Thigh Cellulite in Adult Women
A Phase 2 study, sponsored by Endo USA Inc., a Keenova Therapeutics Company.
- Terminated
- Registry status
- Phase 2
- Development phase
- 7
- Enrollment target
NCT04209530: Clinical Trial Phase 2 study, sponsored by Endo USA Inc., a Keenova Therapeutics Company.
NCT04209530 is a Phase 2 study that was terminated before completion, run by Endo USA Inc., a Keenova Therapeutics Company. The registered enrollment target is 7 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04209530, a Phase 2 study, was terminated before completion, sponsored by Endo USA Inc., a Keenova Therapeutics Company.
- TERMINATED
- Registry status
- Phase 2
- Development phase
- 7 participants
- Enrollment target
Study Summary
This is a single center, open-label, Phase 2a study to assess the photonumeric scale, morphological, and histopathological changes associated with Collagenase Clostridium Histolyticum (CCH) in adult women with moderate or severe Edematous Fibrosclerotic Panniculopathy (EFP).
Interventions
- DRUG EN3835
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 7 participants |
| Start Date | 2019-11-20 |
| Est. Completion | 2020-10-05 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04209530
The ClinicalTrials.gov registry entry for NCT04209530 describes a study currently listed as terminated, categorized as Phase 2. The registered enrollment target is 7 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Endo USA Inc., a Keenova Therapeutics Company, which has 61 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which EN3835 is the first listed.
NCT04209530 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04209530 about?
NCT04209530 is a clinical study titled "Impact of CCH Treatment of Buttock and Thigh Cellulite in Adult Women". This is a single center, open-label, Phase 2a study to assess the photonumeric scale, morphological, and histopathological changes associated with Collagenase Clostridium Histolyticum (CCH) in adult women with moderate or severe Edematous Fibrosclerotic Panniculopathy (EFP).
What is the current status of trial NCT04209530?
This trial is currently terminated. It is a Phase 2 study. The enrollment target is 7 participants. The study started on 2019-11-20. Estimated completion is 2020-10-05.
What interventions are being tested in trial NCT04209530?
The interventions under investigation include: EN3835 (DRUG).
Who is sponsoring clinical trial NCT04209530?
This trial is sponsored by Endo USA Inc., a Keenova Therapeutics Company, which has 61 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.